Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 58
Filter
1.
J Clin Pharm Ther ; 31(6): 599-604, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17176365

ABSTRACT

BACKGROUND AND OBJECTIVE: The objective of this research was to determine the effects of the dietary supplement Echinacea purpurea on aerobic and anaerobic bacteria common to the human gastrointestinal (GI) tract. Botanical extracts have shown in vitro antimicrobial effects against certain pathogenic bacteria. It is uncertain if medicinal herbs have any effect against pathogenic bacteria or on the native GI microbiota. METHODS: Fifteen human subjects consumed 1000 mg of standardized E. purpurea for 10 days. Faecal samples were collected at baseline, 10 days and 17-18 days following supplementation. Samples were tested for select aerobic and anaerobic bacteria using plate culture microbiological methods. RESULTS AND DISCUSSION: Significant increases were found for total aerobic bacteria, Bacteroides group and Bacteroides fragilis after E. purpurea exposure. Supplementation did not significantly alter the number of enteric bacteria, enterococci, lactobacilli, bifidobacteria or total anaerobic bacteria. CONCLUSION: Echinacea supplementation has altered the GI microbiota. The health consequences associated with this change are unknown but previous research has shown increased Bacteroides concentrations associated with diarrhoea, inflammatory bowel disease and increased risk of colon cancer. Additional research should delineate the role of Echinacea in the stimulation of Bacteroides and describe the effects of other botanical supplements to the GI microbiota.


Subject(s)
Colony Count, Microbial , Dietary Supplements , Echinacea , Gastrointestinal Tract/microbiology , Adult , Female , Humans , Male
3.
Am J Pathol ; 157(6): 1975-81, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11106570

ABSTRACT

Skin cells containing excessive ultraviolet (UV) radiation-induced DNA damage are eliminated by apoptosis that involves the p53 pathway and Fas/Fas-Ligand (Fas-L) interactions. To determine whether dysregulation of apoptosis plays a role in skin cancer development through disruption of Fas/Fas-L interactions, hairless SKH-hr1 mice were exposed to chronic UV irradiation from Kodacel-filtered FS40 lamps for 30 weeks. Their skin was analyzed for the presence of sunburn cells (apoptotic keratinocytes) and for Fas and Fas-L expression at various time points. A dramatic decrease in the numbers of morphologically identified sunburn cells and TUNEL-positive cells was detected as early as 1 week after chronic UV exposure began. After 4 weeks of chronic UV exposure, these cells were barely detectable. This defect in apoptosis was paralleled by an initial decrease in Fas-L expression during the first week of chronic UV irradiation and a complete loss of expression after 4 weeks. Fas expression, however, increased during the course of chronic UV exposure. p53 mutations were detected in the UV-irradiated epidermis as early as 1 week after irradiation began and continued to accumulate with further UV exposure. Mice exposed to chronic UV began to develop skin tumors after approximately 8 weeks, and all mice had multiple skin tumors by 24 weeks. Most of the tumors expressed Fas but not Fas-L. We conclude that chronic UV exposure may induce a loss of Fas-L expression and a gain in p53 mutations, leading to dysregulation of apoptosis, expansion of mutated keratinocytes, and initiation of skin cancer.


Subject(s)
Keratinocytes/metabolism , Membrane Glycoproteins/metabolism , Neoplasms, Radiation-Induced/metabolism , Skin Neoplasms/etiology , Skin Neoplasms/metabolism , Ultraviolet Rays , Animals , Fas Ligand Protein , Female , Mice , Mice, Inbred Strains , Mutation , Neoplasms, Radiation-Induced/pathology , Skin Neoplasms/pathology , Sunburn/etiology , Sunburn/pathology , Time Factors , Tumor Suppressor Protein p53/genetics , fas Receptor/metabolism
4.
Crit Care Med ; 28(7): 2420-4, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10921573

ABSTRACT

OBJECTIVE: To determine whether the combination of the phosphodiesterase 5 inhibitor zaprinast and inhaled nitric oxide (NO) decreases hypoxic pulmonary hypertension in the rat. DESIGN: Prospective, experimental study. SETTING: Animal laboratory of a university medical center. SUBJECTS: Male Sprague-Dawley rats. INTERVENTIONS: Anesthetized rats were mechanically ventilated and instrumented for measurement of mean systemic arterial pressure, pulmonary arterial pressure, and cardiac output. In group 1, four acute hypoxic challenges (FIO2 = 0.17 for 5 mins) were performed: initial, during 40 ppm inhaled NO, immediately after discontinuation of 5 mins of inhaled NO, and final. In group 2 rats, an initial hypoxic challenge was performed and rats then received zaprinast (3 mg/kg bolus followed by 0.3 mg/kg/min infusion). Four hypoxic challenges analogous to group 1 were then performed during zaprinast administration. MEASUREMENTS AND MAIN RESULTS: Initial hypoxic challenge produced similar increases in pulmonary arterial pressure in both groups. In group 1, inhaled NO either only before or only during hypoxia decreased the pulmonary hypertensive response to hypoxia. In group 2, zaprinast administration did not alter hemodynamics. Zaprinast alone decreased the pulmonary hypertensive response to hypoxia. The combination of zaprinast and inhaled NO (either before or during hypoxia) abolished the pulmonary hypertensive response to hypoxia. CONCLUSIONS: Treatment with inhaled NO for 5 mins before but not during hypoxia is as effective as inhaled NO during hypoxia. Inhaled NO and zaprinast both decrease the pulmonary hypertensive response to hypoxia, and the combination abolishes the response. The combination of a phosphodiesterase 5 inhibitor and inhaled NO may have clinical applicability in the treatment of pulmonary hypertension.


Subject(s)
Bronchodilator Agents/therapeutic use , Hemodynamics/drug effects , Hypertension, Pulmonary/drug therapy , Nitric Oxide/therapeutic use , Phosphodiesterase Inhibitors/therapeutic use , Purinones/therapeutic use , Administration, Inhalation , Analysis of Variance , Animals , Bronchodilator Agents/administration & dosage , Drug Interactions , Drug Therapy, Combination , Hypoxia/drug therapy , Infusions, Intravenous , Male , Nitric Oxide/administration & dosage , Phosphodiesterase Inhibitors/administration & dosage , Purinones/administration & dosage , Rats , Rats, Sprague-Dawley
5.
Int J Oncol ; 17(1): 5-12, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10853011

ABSTRACT

Apoptosis has been implicated in tumor development and progression. Fas (CD95) and Fas ligand (FasL) are an interacting receptor ligand pair that elicits apoptosis in many cell types. Although originally described as proteins regulating peripheral immune tolerance, accumulating evidence suggests that Fas/FasL may play an important role in carcinogenesis, tumor outgrowth, and metastasis. This review summarizes our current knowledge about the regulation of Fas and FasL expression, Fas signaling, soluble Fas production, the role(s) of Fas and FasL in hematopoietic and non-hematopoietic tumorigenesis and progression, and the potential application of Fas-induced apoptosis in cancer therapy.


Subject(s)
Membrane Glycoproteins/physiology , Neoplasms/pathology , Neoplasms/physiopathology , fas Receptor/physiology , Animals , Apoptosis , Fas Ligand Protein , Genetic Therapy , Humans
7.
J Pathol ; 190(2): 211-20, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10657021

ABSTRACT

This study examined mechanisms contributing to pulmonary immunopathology following acute Mycobacterium tuberculosis (MTB) infection in vivo in a murine model. A/J and C57BL/6 mice were intravenously infected with MTB (Erdman). Pathological differences were found between strains, unrelated to pulmonary load of bacilli. A/J mice developed progressive interstitial pneumonitis, while C57BL/6 mice maintained granuloma formation. The contribution of FAS and FAS ligand-mediated apoptosis was assessed via bioluminescent reverse transcription-polymerase chain reaction (RT-PCR), immunohistochemical staining, and TUNEL assessment of DNA fragmentation. Cytokine messages for pulmonary tumour necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma), as well as for the lytic molecules perforin and granzyme B, were quantified. Immunohistochemical staining for CD3 receptor was performed to monitor lymphocytic lung infiltration. Soon after infection, A/J mice exhibited increased pulmonary IFN-gamma message, concurrent with the appearance of CD3+ lymphocytes distributed throughout the lung. C57BL/6 mice exhibited perivascular cuffing, with no accompanying increase in IFN-gamma message. A/J mice also had elevated levels of FAS and FAS ligand message and protein early after infection, while the C57BL/6 mice had no increased expression of these molecules. Both strains exhibited qualitatively similar numbers of TUNEL-positive cells throughout infection, with a marked increase on day 7. Apoptotic cells appeared to co-localize with acid fast bacilli. It is therefore proposed that apoptosis during initial granuloma formation following MTB infection may occur through a FAS/FAS ligand-independent pathway. Moreover, a failure of completion of the FAS/FAS ligand-mediated apoptosis pathway in the A/J mice may contribute to inefficient elimination of lymphocytes, thus further aggravating pulmonary pathology.


Subject(s)
Apoptosis , Tuberculosis, Pulmonary/immunology , Tuberculosis, Pulmonary/physiopathology , Acute Disease , Animals , CD3 Complex/analysis , Fas Ligand Protein , Interferon-gamma/metabolism , Lung/immunology , Membrane Glycoproteins/metabolism , Mice , Mice, Inbred A , Mice, Inbred BALB C , Perforin , Pore Forming Cytotoxic Proteins , Reverse Transcriptase Polymerase Chain Reaction , T-Lymphocyte Subsets/immunology , Tumor Necrosis Factor-alpha/metabolism , fas Receptor/metabolism
8.
Science ; 285(5429): 898-900, 1999 Aug 06.
Article in English | MEDLINE | ID: mdl-10436160

ABSTRACT

DNA-damaged cells can either repair the DNA or be eliminated through a homeostatic control mechanism termed "cellular proofreading." Elimination of DNA-damaged cells after ultraviolet radiation (UVR) through sunburn cell (apoptotic keratinocyte) formation is thought to be pivotal for the removal of precancerous skin cells. Sunburn cell formation was found to be dependent on Fas ligand (FasL), a pro-apoptotic protein induced by DNA damage. Chronic exposure to UVR caused 14 of 20 (70 percent) FasL-deficient mice and 1 of 20 (5 percent) wild-type mice to accumulate p53 mutations in the epidermis. Thus, FasL-mediated apoptosis is important for skin homeostasis, suggesting that the dysregulation of Fas-FasL interactions may be central to the development of skin cancer.


Subject(s)
DNA Damage , Epidermal Cells , Genes, p53 , Keratinocytes/cytology , Membrane Glycoproteins/physiology , Skin Neoplasms/etiology , Animals , Apoptosis , Epidermis/metabolism , Epidermis/radiation effects , Fas Ligand Protein , Keratinocytes/metabolism , Keratinocytes/radiation effects , Membrane Glycoproteins/genetics , Mice , Mice, Inbred C3H , Mutation , Skin Neoplasms/pathology , Ultraviolet Rays , Up-Regulation , fas Receptor/genetics , fas Receptor/physiology
10.
J Exp Med ; 189(8): 1285-94, 1999 Apr 19.
Article in English | MEDLINE | ID: mdl-10209045

ABSTRACT

Induction of antigen-specific suppression elicited by environmental insults, such as ultraviolet (UV)-B radiation in sunlight, can inhibit an effective immune response in vivo and may contribute to the outgrowth of UV-induced skin cancer. Although UV-induced DNA damage is known to be an initiating event in the immune suppression of most antigen responses, the underlying mechanism(s) of such suppression remain undefined. In this report, we document that Fas ligand (FasL) is critical for UV-induced systemic immune suppression. Normal mice acutely exposed to UV exhibit a profound suppression of both contact hypersensitivity and delayed type hypersensitivity (DTH) reactions and the development of transferable antigen-specific suppressor cells. FasL-deficient mice exposed to UV lack both transferable suppressor cell activity and primary suppression to all antigens tested, with the exception of the DTH response to allogeneic spleen cells. Interestingly, suppression of this response is also known to occur independently of UV-induced DNA damage. Delivery of alloantigen as protein, rather than intact cells, restored the requirement for FasL in UV-induced immune suppression of this response. These results substantiate that FasL/Fas interactions are essential for systemic UV-induced suppression of immune responses that involve host antigen presentation and suggest an interrelationship between UV-induced DNA damage and FasL in this phenomenon. Collectively, our results suggest a model whereby UV-induced DNA damage disarms the immune system in a manner similar to that observed in immunologically privileged sites.


Subject(s)
Immunity/radiation effects , Membrane Glycoproteins/immunology , Animals , Antigen Presentation/immunology , Candida albicans/immunology , DNA Damage/immunology , Dermatitis, Contact/immunology , Fas Ligand Protein , Fluorescein-5-isothiocyanate , Hypersensitivity, Delayed/immunology , Isoantigens/immunology , Mice , Mice, Inbred Strains , Spleen/immunology , T-Lymphocytes/immunology , Ultraviolet Rays , fas Receptor/immunology
11.
J Appl Physiol (1985) ; 86(4): 1160-4, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10194197

ABSTRACT

Inhaled nitric oxide (NO) and inhaled prostacyclin (PGI2) produce selective reductions in pulmonary vascular resistance (PVR) through differing mechanisms. NO decreases PVR via cGMP, and PGI2 produces pulmonary vasodilation via cAMP. As a general pharmacological principle, two drugs that produce similar effects via different mechanisms should have additive or synergistic effects when combined. We designed this study to investigate whether combined inhaled NO and PGI2 therapy results in additive effects during chronic pulmonary hypertension in the rat. Monocrotaline injected 4 wk before study produced pulmonary hypertension in all animals. Inhaled NO (20 parts/million) reversibly and selectively decreased pulmonary artery pressure (Ppa) with a mean reduction of 18%. Four concentrations of PGI2 were administered via inhalation (5, 10, 20, and 80 microg/ml), both alone and combined with inhaled NO. Inhaled PGI2 alone decreased Ppa in a dose-dependent manner with no change in mean systemic arterial pressure. Combined inhaled NO and PGI2 selectively and significantly decreased Ppa more did than either drug alone. The effects were additive at the lower concentrations of PGI2 (5, 10, and 20 microg/ml). The combination of inhaled NO and inhaled PGI2 may be useful in the management of pulmonary hypertension.


Subject(s)
Epoprostenol/therapeutic use , Hypertension, Pulmonary/physiopathology , Nitric Oxide/therapeutic use , Pulmonary Artery/physiopathology , Administration, Inhalation , Animals , Blood Pressure/drug effects , Chronic Disease , Drug Synergism , Epoprostenol/administration & dosage , Hypertension, Pulmonary/chemically induced , Hypertension, Pulmonary/drug therapy , Male , Monocrotaline , Nitric Oxide/administration & dosage , Pulmonary Artery/drug effects , Pulmonary Artery/physiology , Rats , Rats, Sprague-Dawley , Vasodilation/drug effects , Vasodilation/physiology
12.
J Exp Med ; 188(9): 1717-23, 1998 Nov 02.
Article in English | MEDLINE | ID: mdl-9802983

ABSTRACT

Apoptosis induced by Fas (CD95) ligation is frequently lost during tumor progression; however, there is no direct evidence to support an association of Fas loss-of-function with metastatic tumor behavior. To determine whether Fas loss-of-function is critical for acquisition of the metastatic phenotype, we have compared the ability of Fas-sensitive K1735 murine melanomas to form spontaneous lung metastases in wild-type and Fas ligand-deficient mice. Fas-sensitive melanoma clones are highly tumorigenic but rarely metastatic in wild-type syngeneic mice. However, in Fas ligand-deficient mice, both the incidence and number of metastases are increased. These findings provide the first evidence that Fas-Fas ligand interactions can suppress metastasis and that tumor Fas loss-of-function may be causally linked to metastatic progression.


Subject(s)
Lung Neoplasms/immunology , Lung Neoplasms/secondary , Melanoma/immunology , Melanoma/secondary , Membrane Glycoproteins/metabolism , fas Receptor/metabolism , Animals , Apoptosis , Fas Ligand Protein , Ligands , Lung Neoplasms/pathology , Melanoma/pathology , Membrane Glycoproteins/deficiency , Membrane Glycoproteins/genetics , Mice , Mice, Inbred C3H , Mice, Mutant Strains , Tumor Cells, Cultured
13.
West J Med ; 169(3): 184-5, 1998 Sep.
Article in English | MEDLINE | ID: mdl-18751116
14.
Am J Prev Med ; 12(4 Suppl): 8-13, 1996.
Article in English | MEDLINE | ID: mdl-8874698

ABSTRACT

An immunization demonstration project was conducted in an inner-city Latino neighborhood in San Diego to address underimmunization of children of preschool age. The project attempted interventions on consumer, provider, and system levels to reduce barriers to immunization and raise immunization rates. Free walk-in immunization clinics with emphasis on cultural sensitivity and that incorporated computerized reminder/recall were established. An educational series was offered to community health center (CHC) providers, and extensive community-based outreach and education took place in schools, churches, a WIC site, etc. Evaluation activities included preintervention and postintervention provider knowledge, attitudes, and practice surveys, CHC chart audits, and household surveys in the intervention ZIP code area and a control ZIP code area. Immunization coverage for 4DPT, 3OPV, and 1MMR (4:3:1) among two-year-olds increased significantly from 37% to 50% overall, and to 59% in the 1991 birth cohort in the intervention area compared to a one percentage point overall increase in the control area. Coverage improved significantly and missed opportunities decreased in one intervention CHC that participated most actively in educational inservices. While the Year 2000 U.S. Public Health Service objective of 90% 4:3:1 coverage for two-year-olds was not achieved over the 21-month course of the project, the results approached the 1996 single-antigen objectives. This demonstration underscores the importance of multilevel interventions including low cost, no appointment, and culturally appropriate immunization services for the indigent; the use of computerized reminder systems; and provider assessment, education, and feedback in the effort to raise preschool immunization levels. Medical Subject Headings (MeSH): immunization, preschool-age children, health promotion, provider education, immunization monitoring and follow-up systems, pediatric immunization standards, household surveys.


Subject(s)
Hispanic or Latino , Immunization Programs/organization & administration , Models, Organizational , Urban Health Services/organization & administration , California , Child, Preschool , Health Promotion , Humans
15.
Psychol Rep ; 74(2): 491-4, 1994 Apr.
Article in English | MEDLINE | ID: mdl-8197286

ABSTRACT

This paper provides preliminary data on sexual functioning within a sample of 19 Russian geriatric respondents who completed selected items from the Starr-Weiner questionnaire assessing areas such as sexual interest and frequency, sexual dysfunction, and sexual attitudes. All 8 men and 9 of the women reported being sexually active. Like American seniors, differences in activity appeared to be moderated by gender and over-all physical health. Sexual dysfunction among these Russians was less than that reported by Stern and Stern in 1979. Also, the Russian seniors reported tolerance toward sexual topics such as homosexuality. Finally, limitations of the present study and research recommendations are mentioned.


Subject(s)
Geriatric Assessment , Sexual Behavior/psychology , Aged , Attitude , Female , Health Status , Homosexuality , Humans , Libido , Male , Pilot Projects , Russia , Sex Factors
16.
Alcohol Alcohol ; 29(2): 203-9, 1994 Mar.
Article in English | MEDLINE | ID: mdl-7980831

ABSTRACT

The influence of response options for and location of frequency of alcohol use items in a self-administered microcomputer interview were evaluated in a randomized, experimental study of 296 clients at a west coast treatment site for drinking drivers. Respondents were asked about their frequency of alcohol use in the last 7 days, 30 days, 90 days, and 180 days with three methodological factors randomized: (1) how quantitative the response options were; (2) order of presentation of close-ended response options; and (3) relative placement of alcohol use items in the questionnaire. Results indicate that these methodological factors had minimal influence on self-reports of the frequency of alcohol use. Only two statistically significant effects out of 44 possible were observed. The findings of this study suggest that frequency of alcohol use reports by drinking drivers yield similar information for a range of different response formats and location of the items in a microcomputer interview.


Subject(s)
Alcohol Drinking/legislation & jurisprudence , Alcoholic Intoxication/epidemiology , Automobile Driving/legislation & jurisprudence , Microcomputers , Personality Assessment/statistics & numerical data , Truth Disclosure , Adult , Aged , Alcohol Drinking/prevention & control , Alcoholic Intoxication/prevention & control , Alcoholic Intoxication/psychology , California , Female , Humans , Male , Middle Aged , Psychometrics , Reproducibility of Results
18.
Cancer Res ; 54(3): 763-70, 1994 Feb 01.
Article in English | MEDLINE | ID: mdl-8306339

ABSTRACT

An in vivo model for human melanoma was established with the growth of CR3 and DE5 human melanoma tumor cells following i.v. injection into C.B.-17 severe combined immunodeficient mice depleted of murine natural killer (NK) cells. The ability of human NK cells to mediate antitumor activity in vivo was investigated by evaluating the number of lung nodules and survival of mice given injections of human NK cells i.v. early after injection of CR3 tumor cells. Under these conditions, human NK cells effectively reduced lung nodule counts and prolonged survival when coinjected with interleukin 2 (IL-2). Multiple injections of IL-2 given during the first 16 h post-NK injection did not further enhance the tumor reduction. Significantly increased antitumor activity against CR3 tumor cells in vivo was observed in mice receiving NK cells coinjected with IL-2 and interleukin 12 (IL-12) in comparison to NK cells and IL-2 only. However, coinjection of IL-12 with human NK cells alone did not reduce the tumor burden. These results demonstrate the antitumor activity of human NK cells against human melanoma in severe combined immunodeficient mice and its augmentation by IL-2, alone or in combination with IL-12, suggesting that this model can be used to further investigate the interaction between human NK cells and human tumors.


Subject(s)
Immunotherapy, Adoptive , Killer Cells, Natural/physiology , Melanoma/secondary , Melanoma/therapy , Animals , Cell Division/drug effects , Cell Division/physiology , Cells, Cultured , Female , Humans , Interleukin-2/pharmacology , Male , Melanoma/immunology , Mice , Mice, SCID , Neoplasm Transplantation , Transplantation, Heterologous , Tumor Cells, Cultured
19.
Clin Nephrol ; 39(5): 245-9, 1993 May.
Article in English | MEDLINE | ID: mdl-8513599

ABSTRACT

The clinical courses of five children with the nephrotic syndrome and renal biopsies diagnosed as minimal change disease (MCD) by light microscopy but with mesangial immune deposits of IgG (> or = 2+) and no dominant or codominant IgA were reviewed retrospectively to determine if the presence of significant mesangial deposits of IgG has prognostic implications and to evaluate the treatment these patients received. All five of the children were steroid dependent or resistant initially, and four received cyclosporine or cytotoxic agents later. After a mean follow-up period of 2.9 years for four and 20 years for one, all are in remission. All have normal renal function with no hypertension. These results suggest that the deposition of IgG in the mesangium of biopsies from patients with MCD by light microscopy may predict a more difficult course initially and may require more aggressive treatment to achieve permanent remission.


Subject(s)
Glomerular Mesangium/immunology , Immunoglobulin G/analysis , Nephrosis, Lipoid/immunology , Biopsy , Child, Preschool , Chlorambucil/therapeutic use , Cyclophosphamide/therapeutic use , Cyclosporine/therapeutic use , Fluorescent Antibody Technique , Follow-Up Studies , Humans , Infant , Nephrosis, Lipoid/drug therapy , Nephrosis, Lipoid/epidemiology , Prednisone/therapeutic use , Prognosis , Retrospective Studies
20.
Clin Pediatr (Phila) ; 31(3): 153-7, 1992 Mar.
Article in English | MEDLINE | ID: mdl-1547587

ABSTRACT

To determine the frequency, causes, and clinical significance of hyponatremia in hospitalized children, we reviewed the clinical and laboratory data of all hyponatremic children in Texas Children's Hospital over a 12-month period. One hundred sixty-one patients from among 11,702 hospital admissions were found to have hyponatremia, defined as serum sodium value of less than 130 mEq/L, an overall frequency of 1.38%. Sixty-nine patients (43%) had hyponatremia on admission, and 92 patients (57%) had hospital-acquired hyponatremia. Thirty-seven (23%) were previously healthy children, and 124 (77%) had chronic illnesses. Acute gastroenteritis was the leading cause of hyponatremia present on admission, and diuretic therapy was the leading cause of hospital-acquired hyponatremia. Only four patients (2.5%) had a serum sodium concentration of less than 120 mEq/L. Six patients (3.7%) had neurologic impairment on discharge, and 19 patients (12%) ultimately died long after their hyponatremia was corrected. Each patient who had neurologic sequelae and each patient who died had underlying medical conditions which could explain their morbidity and/or mortality. The prognosis appears to be more clearly related to the underlying medical disorder rather than to the hyponatremic state or its correction.


Subject(s)
Hyponatremia/epidemiology , Adolescent , Child , Child, Hospitalized , Child, Preschool , Chronic Disease , Diuretics/adverse effects , Edema/complications , Female , Gastroenteritis/complications , Humans , Hyponatremia/blood , Hyponatremia/drug therapy , Hyponatremia/etiology , Hyponatremia/physiopathology , Infant , Isotonic Solutions , Male , Retrospective Studies , Sodium/blood , Sodium Chloride/therapeutic use , Texas/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...